"EU Pharma Legislation Overhaul: Implications for Industry and Patients"

The European Commission has unveiled draft reforms to overhaul its 20-year-old pharma legislation, which includes new perks for the industry but also stricter regulatory data protection limits for companies that don’t introduce new drugs across all member states. The reforms aim to update the current legislation to reflect the latest scientific and technological developments, as well as to improve access to medicines and patient safety.